Sharps Technology Inc (STSS) USD0.0001

Sell:$0.34Buy:$0.35$0.01 (3.59%)

Prices delayed by at least 15 minutes
Sell:$0.34
Buy:$0.35
Change:$0.01 (3.59%)
Prices delayed by at least 15 minutes
Sell:$0.34
Buy:$0.35
Change:$0.01 (3.59%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Key people

Robert M. Hayes
Chief Executive Officer, Director
Andrew R. Crescenzo
Chief Financial Officer
Soren Bo Christiansen
Chairman of the Board
Paul K. Danner
Independent Director
Jason L. Monroe
Independent Director
Timothy J. Ruemler
Independent Director
Brenda Baird Simpson
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US82003F2002
  • Market cap
    $1.82m
  • Employees
    3
  • Shares in issue
    5.50m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.